HIV-2 (NIH-Z Strain) Purified Virus
产品名称: HIV-2 (NIH-Z Strain) Purified Virus
英文名称: HIV-2 (NIH-Z Strain) Purified Virus
产品编号: HIV-2 (NIH-Z Strain) Purified Virus
产品价格: 0
产品产地: 美国
品牌商标:
更新时间: 2023-09-19T20:51:30
使用范围: null
Biohazard Category A Description(产品描述):
Description(名称)
HIV-2 (NIH-Z Strain) Purified Virus
Catalog #(货号)
10-127-000
Size(规格)
1.0 mg
Price(价格)
请联系:0769-2289-0558, 0769-22890598, QQ:2533190771
Human Immunodeficiency Virus type 2 (NIH-Z strain) propagated in HuT 78 cells and purified from culture supernatant and cells showing cytopathic effect.
For research use only. Not for use in diagnostic procedures.
Purified Infectious Viruses offered by ABI are a valuable asset for the research community. We have experience with many virus families, including: Orthomyxoviridae, Paramyxoviridae, Retroviridae, Poxviridae, Herpesviridae, Picornaviridae, Adenoviridae, Togaviridae, and others. ABI also offers custom start-to-finish virus propagation, purification and characterization services.
Details(注意事项):
Shipping and Storage: This product is shipped frozen on dry ice. Store at -70°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.
Recommendations: Upon thawing, centrifuge the vial for a few seconds to remove residual droplets from the lid.
Safe Handling Recommendation: This preparation of HIV is a BIOHAZARDOUS material containing ACTIVE VIRUSand should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. 93-8395.
Applications for use(适用范围):
- In vitro Infectivity Assay
- Antiviral Studies
- Animal Experimentation
- Nucleic Acid Extraction
- Spiking Studies
- ELISpot Assay
- Virus Neutralization Assay
- Virus Ultrastructural Studies
Quality control testing includes(质量控制检测包括):
- Sterility
- TCID50
- Protein Concentration
- Virus Particle Count
Certificate of Analysis(分析报告):
Reference Articles(已发表参考文献):
Drylewicz J, Matheron S, Lazaro E, et al. “Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.” AIDS. 2008;22(4).
Zhang Z, Xu W, Koh Y-H, et al. “A Novel Nonnucleoside Analogue That Inhibits Human Immunodeficiency Virus Type 1 Isolates Resistant to Current Nonnucleoside Reverse Transcriptase Inhibitors.” Antimicrobial Agents and Chemotherapy. 2007;51(2):429-437.
Zheng NN, McElrath MJ, Sow P-S, et al. “Role of Human Immunodeficiency Virus (HIV)-Specific T-Cell Immunity in Control of Dual HIV-1 and HIV-2 Infection.” Journal of Virology. 2007;81(17):9061-9071.
Zhang Z, Walker M, Xu W, et al. “Novel Nonnucleoside Inhibitors That Select Nucleoside Inhibitor Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase.” Antimicrobial Agents and Chemotherapy. 2006;50(8):2772-2781.